Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

290.22 +3.64 (+1.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Navigating The S&P 500 Landscape: Here Are The Stocks Analysts Believe Have The Highest Potential And Biggest Downside
In the middle of the AI revolution and the Federal Reserve's steadfast stance on interest rates, the stock market has seen unexpected twists and turns. Despite hopes of the U.S. 
Via Benzinga
Topics Artificial Intelligence Stocks
The 7 Most Undervalued Stocks in the Market Right Now: September 2023
Buying these undervalued stocks right now can pay off tremendously once these fundamentally solid businesses ultimately recover. 
Via InvestorPlace
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood... 
Via Benzinga
Why Insulet Stock Is Sinking Today
Comments from Insulet's CEO at a major healthcare conference rattled investors. 
Via The Motley Fool
What 12 Analyst Ratings Have To Say About Insulet
 
Via Benzinga
What 8 Analyst Ratings Have To Say About Insulet
 
Via Benzinga
Expert Ratings for Insulet
 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?
The S&P 500 had a rare decline last month. 
Via The Motley Fool
Topics Stocks
Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar
Dexcom says the popularity of GLP-1 drugs won't hurt its continuous glucose monitors. 
Via Investor's Business Daily
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for... 
Via Benzinga
The 3 Most Promising Healthcare Stocks to Own Now
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products. 
Via InvestorPlace
Why Insulet Stock Rocked the Market Today
The company's leader signals a giant vote of confidence in its future. 
Via The Motley Fool
Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
$1M Bet On Lyft? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 99 stocks hit new 52-week lows. 
Via Benzinga
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany
From Insulet Corporation
Via Business Wire
Morgan Stanley Maintains Equal-Weight Rating for Insulet: Here's What You Need To Know
 
Via Benzinga
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
 
Via Benzinga
NVIDIA To Rally Over 80%? Here Are 10 Other Analyst Forecasts For Monday
Credit Suisse lowered the price target for The Walt Disney Company (NYSE: DIS) from $126 to $122. Credit Suisse analyst Douglas Mitchelson maintained an Outperforn rating. Disney shares gained 0.4% to... 
Via Benzinga
JP Morgan Bullish On Insulet, Forecasts Robust Pump Market with Long Runway for Growth
J.P. 
Via Benzinga
Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)
From Insulet Corporation
Via Business Wire
Where to Invest $5,000 for the Next 20 Years
These are high-growth opportunities investors should focus on for the long haul. 
Via The Motley Fool
Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens
This elite eight meet long-term growth criteria for sales and earnings. 
Via Investor's Business Daily
Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
From Insulet Corporation
Via Business Wire
Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers
 
Via Benzinga
Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions
From Insulet Corporation
Via Business Wire
Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom
From Insulet Corporation
Via Business Wire
Medtronic's EOflow Acquisition Will Not Impact Insulet's Omnipod' Insulin Pump In Near or Medium Term: Analyst
 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.